Locus,Allele,Disease
MT-ATP6,m.8573G>A,Patient with suspected mitochondrial disease
MT-ATP6,m.8578C>T,Spinocerebellar ataxia
MT-ATP6,m.8597T>C,Leigh Syndrome
MT-ATP6,m.8606C>T,Possible association with sepsis
MT-ATP6,m.8608C>T,Patient with suspected mitochondrial disease
MT-ATP6,m.8611_8612insC,"Ataxia, microcephaly, developmental delay, intellectual disability"
MT-ATP6,m.8612T>C,"Arm and leg weakness, incontinence, developmental delay, autism, epilepsy"
MT-ATP6,m.8618_8619insT,NARP/cognitive decline+abnormal brain MRI+impaired kidney function
MT-ATP6,m.8639T>C,Possible LHON modulator
MT-ATP6,m.8668T>C,LHON
MT-ATP6,m.8691A>G,Infantile mito disease w subclinical hypothyroidism
MT-ATP6,m.8719G>A,Suspected mito disease
MT-ATP6,m.8723G>T,Patient with suspected mitochondrial disease
MT-ATP6,m.8741T>G,MILS protective factor
MT-ATP6,m.8777T>C,Adult-onset cerebellar ataxia
MT-ATP6,m.8779C>T,Possible LHON modulator
MT-ATP6,m.8782G>A,Cerebellar ataxia+diabetes+kidney disease / ataxia+myoclonic epilepsy
MT-ATP6,m.8783G>A,Unspecified suspected mitochondrial disorder
MT-ATP6,m.8794C>T,Exercise Endurance / Coronary Atherosclerosis risk
MT-ATP6,m.8795A>G,MILS protective factor
MT-ATP6,m.8806C>G,Suspected mito disease
MT-ATP6,m.8812A>G,Spinocerebellar ataxia
MT-ATP6,m.8821T>G,Possible LHON helper variant
MT-ATP6,m.8836A>G,LHON
MT-ATP6,m.8839G>C,NARP syndrome
MT-ATP6,m.8843T>C,Patient with suspected mitochondrial disease
MT-ATP6,m.8851T>C,BSN / Leigh syndrome
MT-ATP6,m.8879G>T,Adult-onset cerebellar ataxiaÂ - possible helper mutant for m.8777C
MT-ATP6,m.8881T>C,Patient with suspected mitochondrial disease
MT-ATP6,m.8890A>G,Juvenile-onset metabolic syndrome
MT-ATP6,m.8902G>A,Suspected mito disease
MT-ATP6,m.8909T>C,Recurrent severe kidney disease and multiple systemic dysfunctions
MT-ATP6,m.8921G>A,Patient with suspected mitochondrial disease
MT-ATP6,m.8932C>T,Prostate tumor / Neuromuscular disorder
MT-ATP6,m.8936T>A,Atypical Leigh syndrome
MT-ATP6,m.8938A>G,Patient with suspected mitochondrial disease
MT-ATP6,m.8950G>A,LDYT / Spinocerebellar Ataxia
MT-ATP6,m.8951T>C,Patient with ataxia
MT-ATP6,m.8959G>A,"Developmental delay, intellectual disability, low citrilline"
MT-ATP6,m.8969G>A,"Mitochondrial myopathy, lactic acidosis and sideroblastic anemia (MLASA) / IgG nephropathy"
MT-ATP6,m.8969G>C,Suspected mito disease
MT-ATP6,m.8975T>C,Suspected mito disease
MT-ATP6,m.8989G>C,NARP syndrome
MT-ATP6,m.8993T>C,NARP / Leigh Disease / MILS / other
MT-ATP6,m.8993T>G,NARP / Leigh Disease / MILS / other
MT-ATP6,m.8993TG>CA,Developmental delay & myopathy
MT-ATP6,m.8999T>C,Patient with suspected mitochondrial disease
MT-ATP6,m.9008C>G,Suspected mito disease
MT-ATP6,m.9010G>A,Unspecified neurological disorder
MT-ATP6,m.9016A>G,LHON
MT-ATP6,m.9017T>C,Unspecified neurological disorder
MT-ATP6,m.9019A>G,Suspected mito disease
MT-ATP6,m.9025G>A,"Motor neuropathy, Leigh-like, colon cancer"
MT-ATP6,m.9026G>A,Spinocerebellar ataxia / patient with suspected mitochondrial disease
MT-ATP6,m.9029A>G,LHON-like
MT-ATP6,m.9032T>C,"NARP / Complex phenotype with microcephaly, ataxia, hearing loss, lactic acidosis"
MT-ATP6,m.9035T>C,Ataxia syndromes
MT-ATP6,m.9041A>G,Patient with suspected mitochondrial disease
MT-ATP6,m.9049G>A,Unspecified suspected mitochondrial disorder
MT-ATP6,m.9055G>A,PD protective factor
MT-ATP6,m.9058A>G,"Patients with (1) LVNC cardiomyopathy; (2) autism, intellectual disability, epilepsy"
MT-ATP6,m.9071C>T,Potentially functional variant cosegregating with LHON3635A
MT-ATP6,m.9088T>C,Patient with suspected mitochondrial disease
MT-ATP6,m.9098T>C,Predisposition to anti-retroviral mito disease
MT-ATP6,m.9101T>C,LHON
MT-ATP6,m.9115A>G,Patient with suspected mitochondrial disease
MT-ATP6,m.9127_9128del,NARP
MT-ATP6,m.9133G>A,Patient with suspected mitochondrial disease
MT-ATP6,m.9134A>G,"Hypotonia, lactic acidosis, HCM, IUGR"
MT-ATP6,m.9139G>A,LHON
MT-ATP6,m.9152T>C,Patient with suspected mitochondrial disease
MT-ATP6,m.9154C>T,Peripheral neuropathy ataxia IgA nephropathy
MT-ATP6,m.9155A>G,"MIDD, renal insufficiency"
MT-ATP6,m.9155A>T,"Developmental delay, intellectual disability, low citrilline"
MT-ATP6,m.9166T>C,EXIT+more /  bilateral optic neuropathy
MT-ATP6,m.9176T>C,FBSN / Leigh Disease / Spinocerebellar Ataxia
MT-ATP6,m.9176T>G,Leigh Disease / Spastic Paraplegia / Spinocerebellar Ataxia
MT-ATP6,m.9185T>C,Leigh Disease / Ataxia syndromes / NARP-like disease / Episodic weakness and Charcot-Marie-Tooth
MT-ATP6,m.9191T>C,Leigh Disease
MT-ATP6,m.9205_9206del,Encephalopathy / Seizures / Lacticacidemia
MT-ATP8,m.8381A>G,MIDD / LVNC cardiomyopathy-assoc.
MT-ATP8,m.8382C>T,Suspected mito disease / optic neuropathy
MT-ATP8,m.8393C>T,Reversible brain pseudoatrophy
MT-ATP8,m.8403T>C,Episodic weakness and progressive neuropathy
MT-ATP8,m.8411A>G,Severe mitochondrial disorder
MT-ATP8,m.8412T>C,Possible LHON helper mutation
MT-ATP8,m.8414C>T,Increased risk of T2DM and high altitude polycythemia (HAPC) in haplogroup D4 / Longevity
MT-ATP8,m.8418T>C,Severe bilateral optic neuropathy
MT-ATP8,m.8424T>C,Suspected mito disease
MT-ATP8,m.8481C>T,Tetralogy of Fallot patient
MT-ATP8,m.8490T>C,Peripheral neuropathy of T2DM
MT-ATP8,m.8519G>A,Possible susceptibility to bullous pemphigoid
MT-ATP8/6,m.8527A>G,"Neuromuscular disorder, possible helper mutation"
MT-ATP8/6,m.8528T>C,Infantile cardiomyopathy / hyperammonemia
MT-ATP8/6,m.8529G>A,Apical HCM
MT-ATP8/6,m.8551T>C,Possible LHON helper mutation
MT-ATP8/6,m.8558C>T,Possibly LVNC cardiomyopathy-associated
MT-ATP8/6,m.8561C>G,"Ataxia w neuropathy, DM, SNHL, and hypogonadism"
MT-ATP8/6,m.8561C>T,Ataxia w psychomotor delay
MT-ATP8/6,m.8572G>A,Spinocerebellar ataxia
MT-CO1,m.5906G>A,MELAS/Leigh overlap Syndrome
MT-CO1,m.5911C>T,Prostate Cancer
MT-CO1,m.5913G>A,Prostate Cancer / hypertension
MT-CO1,m.5920G>A,Myoglobinuria / EXIT
MT-CO1,m.5935A>G,Prostate Cancer
MT-CO1,m.5973G>A,Prostate Cancer
MT-CO1,m.6020C>A,Possible association with sepsis
MT-CO1,m.6020_6024del,Motor Neuron Disease
MT-CO1,m.6081G>A,Prostate Cancer
MT-CO1,m.6145G>A,Unspecified suspected mitochondrial disorder
MT-CO1,m.6150G>A,Prostate Cancer / POAG (primary open-angle glaucoma) risk factor
MT-CO1,m.6253T>C,Prostate Cancer / enriched in POAG cohort
MT-CO1,m.6261G>A,Prostate Cancer / LHON
MT-CO1,m.6267G>A,Prostate Cancer
MT-CO1,m.6285G>A,Prostate Cancer
MT-CO1,m.6307A>G,Asthenozoospermic infertility
MT-CO1,m.6328C>T,EXIT (Exercise Intolerance)
MT-CO1,m.6340C>T,Prostate Cancer
MT-CO1,m.6367T>C,Possible association with sepsis
MT-CO1,m.6459T>C,Sepsis susceptibility
MT-CO1,m.6474A>G,Maternally inherited childhood epilepsy and ataxia
MT-CO1,m.6480G>A,Prostate Cancer / enriched in POAG cohort
MT-CO1,m.6489C>A,CO1 deficiency with epilepsia partialis continua
MT-CO1,m.6526T>C,"Developmental delay, hypotonia, myopathy, failure to thrive"
MT-CO1,m.6544A>C,Possible association with sepsis
MT-CO1,m.6547T>C,Leigh Syndrome
MT-CO1,m.6579G>A,Leigh Syndrome
MT-CO1,m.6597C>A,MELAS-like syndrome
MT-CO1,m.6649C>T,Possible association with sepsis
MT-CO1,m.6663A>G,Prostate Cancer
MT-CO1,m.6698del,Myopathy
MT-CO1,m.6708G>A,MM & Rhabdomyolysis
MT-CO1,m.6721T>C,Acquired Idiopathic Sideroblastic Anemia
MT-CO1,m.6742T>C,Acquired Idiopathic Sideroblastic Anemia
MT-CO1,m.6860A>C,Dilated Cardiomyopathy
MT-CO1,m.6930G>A,Multisystem Disorder
MT-CO1,m.6955G>A,Mild EXIT and MR
MT-CO1,m.6962G>A,Possible helper variant for 15927A
MT-CO1,m.7023G>A,MELAS-like syndrome
MT-CO1,m.7041G>A,Prostate Cancer
MT-CO1,m.7065G>A,Possible association with sepsis
MT-CO1,m.7080T>C,Prostate Cancer
MT-CO1,m.7083A>G,Prostate Cancer
MT-CO1,m.7158A>G,Prostate Cancer
MT-CO1,m.7222A>G,Mitochondrial myopathy
MT-CO1,m.7299A>G,LHON
MT-CO1,m.7305A>C,Prostate Cancer
MT-CO1,m.7379G>A,Possible association with sepsis
MT-CO1,m.7402del,Isolated complex IV deficiency
MT-CO1,m.7443A>G,DEAF
MT-CO1,m.7444G>A,LHON / SNHL / DEAF modulator
MT-CO1,m.7445A>C,DEAF
MT-CO1,m.7445A>G,SNHL
MT-CO1,m.7445A>T,SNHL
MT-CO2,m.7587T>C,Mitochondrial Encephalomyopathy
MT-CO2,m.7598G>A,Possible LHON helper variant
MT-CO2,m.7623C>T,LHON
MT-CO2,m.7630del,MELAS
MT-CO2,m.7637G>A,PD risk factor / neurological impairment
MT-CO2,m.7671T>A,MM
MT-CO2,m.7695T>C,Cerebellar and pyramidal syndrome with cognitive impairment
MT-CO2,m.7697G>A,"Possible HCM susceptibility, high altitude adaptation"
MT-CO2,m.7706G>A,Alpers-Huttenlocher-like
MT-CO2,m.7749T>C,Possible association with sepsis
MT-CO2,m.7859G>A,Progressive Encephalomyopathy
MT-CO2,m.7868C>T,LHON
MT-CO2,m.7877A>C,PEG glaucoma
MT-CO2,m.7887G>A,Cerebellar ataxia + neuropathy + exercise intolerance
MT-CO2,m.7896G>A,Multisystem Disorder
MT-CO2,m.7943T>C,Possible association with sepsis
MT-CO2,m.7965T>C,Hepatic failure / COX deficiency
MT-CO2,m.7970G>T,Encephalopathy
MT-CO2,m.7989T>C,Rhabdomyolysis
MT-CO2,m.8010T>C,"Developmental delay, ataxia, seizure, hypotonia, lactic acidosis"
MT-CO2,m.8021A>G,Asthenozoospermia
MT-CO2,m.8042_8043del,Lactic Acidosis
MT-CO2,m.8078G>A,DEAF
MT-CO2,m.8088del,Mitochondrial myopathy with complex IV deficiency
MT-CO2,m.8108A>G,SNHL
MT-CO2,m.8119del,Biliary atresia
MT-CO2,m.8156del,Multi-system mitochondrial disorder
MT-CO2,m.8163A>G,Late-onset cerebellar ataxia
MT-CO2,m.8231C>A,Coronary artery disease risk factor
MT-CO2,m.8241T>G,MIDD+retinopathy
MT-CO2,m.8249G>A,Mitochondrial myopathy
MT-CO3,m.9237G>A,Mitochondrial Respiratory Chain Disorder
MT-CO3,m.9247G>C,MELAS
MT-CO3,m.9266G>T,Possible association with sepsis
MT-CO3,m.9267G>C,MIDD
MT-CO3,m.9331T>C,"Failure to thrive with metabolic acidosis, cognitive impairment, optic atrophy"
MT-CO3,m.9379G>A,MM w lactic acidosis
MT-CO3,m.9387G>A,Asthenozoospermia
MT-CO3,m.9399A>G,"Patient with epilepsy, myopathy, hypoacusis, psychiatric disorders"
MT-CO3,m.9403C>A,Possible association with sepsis
MT-CO3,m.9415A>G,Possible association with sepsis
MT-CO3,m.9438G>A,LHON / gout
MT-CO3,m.9444C>T,Possible LHON helper mutation
MT-CO3,m.9478T>C,Leigh Disease
MT-CO3,m.9480_9494del,Myoglobinuria
MT-CO3,m.9487_9501del,Myoglobinuria
MT-CO3,m.9490C>T,Gout
MT-CO3,m.9537_9538insC,Leigh Disease
MT-CO3,m.9544G>A,Sporadic bilateral optic neuropathy
MT-CO3,m.9553G>A,Adult-onset MELAS
MT-CO3,m.9559del,Rhabdomyolysis
MT-CO3,m.9660A>C,LHON
MT-CO3,m.9738G>T,LHON
MT-CO3,m.9789T>C,Myopathy
MT-CO3,m.9804G>A,LHON / MS
MT-CO3,m.9856T>C,LVNC cardiomyopathy / gout
MT-CO3,m.9861T>C,AD
MT-CO3,m.9907G>A,Cavitating leukodystrophy
MT-CO3,m.9921G>A,Possible LHON helper mutation
MT-CO3,m.9952G>A,Mitochondrial Encephalopathy
MT-CO3,m.9957T>C,PEM / MELAS / NAION / HCM / gout
MT-CO3,m.9966G>A,LHON possible helper variant
MT-CO3,m.9972A>C,EXIT & APS2 - possible link
MT-CO3,m.9984G>A,Suspected mito disease
MT-CR,m.72T>C,Protective factor for stroke risk (hg V)
MT-CR,m.114C>T,BD-associated
MT-CR,m.146T>C,Absence of Endometriosis
MT-CR,m.150C>T,Longevity / Cervical Carcinoma / HPV infection risk
MT-CR,m.195T>C,BD-associated / melanoma pts
MT-CR,m.309_310insC,AD-weakly associated
MT-CR,m.309_310insCC,Higher in melanoma patient group
MT-CR,m.310T>C,Possible protective factor for normal tension glaucoma
MT-CR,m.315_316insC,Melanoma patients
MT-CR,m.351A>G,Patient with CPEO
MT-CR,m.499G>A,Endometriosis / possible protective factor for high altitude sicknes
MT-CR,m.547A>T,Tubulointerstitial kidney disease
MT-CR,m.573_574insCC,Absence of Endometriosis
MT-CR,m.576A>G,Hearing loss patient
MT-CR,m.16051A>G,Possible susceptibility to bullous pemphigoid
MT-CR,m.16081A>G,Cyclic Vomiting Syndrome
MT-CR,m.16093T>C,Cyclic Vomiting Syndrome / Increased risk of breast cancer
MT-CR,m.16129G>A,Cyclic Vomiting Syndrome with Migraine
MT-CR,m.16162A>G,Possible susceptibility to bullous pemphigoid
MT-CR,m.16176C>T,Cyclic Vomiting Syndrome with Migraine
MT-CR,m.16183A>C,Melanoma patients
MT-CR,m.16188_16189insC,Possible association with sepsis
MT-CR,m.16189T>C,Diabetes / Cardiomyopathy /cancer risk / mtDNA copy nbr / Metabolic Syndrome / Melanoma patients
MT-CR,m.16192C>T,Melanoma patients
MT-CR,m.16217T>C,Endometriosis
MT-CR,m.16263T>C,Possible susceptibility to bullous pemphigoid
MT-CR,m.16270C>T,Melanoma patients
MT-CR,m.16298T>C,Protective factor for stroke risk (hg V)
MT-CR,m.16300A>G,BD-associated
MT-CR,m.16318A>C,Non-alcoholic steatohepatitis - potential for association
MT-CR,m.16390G>A,POAG - potential for association
MT-CR,m.16519=,Cyclic Vomiting Syndrome with Migraine /metastasis
MT-CYB,m.14783T>C,Possible role in high altitude sickness
MT-CYB,m.14787_14790del,PD / MELAS
MT-CYB,m.14831G>A,LHON
MT-CYB,m.14841A>G,LHON helper mut.
MT-CYB,m.14846G>A,"EXIT / possibly antiatherogenic, poss. myocardial infarction association"
MT-CYB,m.14849T>C,EXIT / Septo-Optic Dysplasia
MT-CYB,m.14864T>C,MELAS
MT-CYB,m.14894T>C,LHON
MT-CYB,m.14970A>G,LHON
MT-CYB,m.15024G>A,Possible DEAF modifier
MT-CYB,m.15043G>A,MDD-associated / possible factor in high altitude sickness
MT-CYB,m.15059G>A,MM / carotid atherosclerosis risk / essential hypertension
MT-CYB,m.15060G>A,Mitochondrial Respiratory Chain Disorder
MT-CYB,m.15077G>A,DEAF / LHON / helper mutation for maternally inherited hypertension
MT-CYB,m.15084G>A,EXIT
MT-CYB,m.15092G>A,MELAS
MT-CYB,m.15150G>A,EXIT
MT-CYB,m.15153G>A,Suspected mito disease
MT-CYB,m.15158A>G,Suspected mito disease
MT-CYB,m.15168G>A,EXIT
MT-CYB,m.15170G>A,EXIT
MT-CYB,m.15197T>C,EXIT
MT-CYB,m.15200G>T,Possible factor in sepsis
MT-CYB,m.15209T>C,Prader-Willi syndrome
MT-CYB,m.15215G>A,MELAS
MT-CYB,m.15218A>G,Possible LHON modulator
MT-CYB,m.15234G>A,Leigh stroke-like leukodystrophy
MT-CYB,m.15236A>G,Possible LHON helper (one 11778 patient)
MT-CYB,m.15237T>C,Potentially functional variant cosegregating with LHON3635A
MT-CYB,m.15242G>A,Mitochondrial Encephalomyopathy
MT-CYB,m.15243G>A,HCM
MT-CYB,m.15246G>A,Mitochondrial Respiratory Chain Disorder
MT-CYB,m.15256A>G,Peripheral neuropathy of T2 diabetes
MT-CYB,m.15257G>A,LHON
MT-CYB,m.15287T>C,Possible DEAF helper mut.
MT-CYB,m.15301G>A,"Possible factor in high altitude sickness, LHON"
MT-CYB,m.15324C>G,Possible LHON helper (one 11778 patient)
MT-CYB,m.15350G>A,Possible sepsis factor
MT-CYB,m.15395A>G,Possible LHON factor
MT-CYB,m.15436C>A,Possible role in high altitude sickness
MT-CYB,m.15453T>C,Isolated complex III deficiency
MT-CYB,m.15485C>T,Suspected mitochondrial disorder
MT-CYB,m.15497G>A,EXIT / Obesity
MT-CYB,m.15498_15521del,EXIT
MT-CYB,m.15498G>A,DEAF / Infantile histiocytoid cardiomyopathy
MT-CYB,m.15579A>G,"Multisystem Disorder, EXIT"
MT-CYB,m.15615G>A,EXIT / Antimycin resistance
MT-CYB,m.15620C>A,Leigh Syndrome helper mut
MT-CYB,m.15635T>C,Polyvisceral failure / adult Leigh syndrome
MT-CYB,m.15649_15666del,"Multisystem Disorder, EXIT"
MT-CYB,m.15662A>G,Complex mitochondriopathy-associated
MT-CYB,m.15674T>C,LHON
MT-CYB,m.15693T>C,Possibly LVNC cardiomyopathy-associated
MT-CYB,m.15699G>C,Muscle Weakness SNHL and Migraine
MT-CYB,m.15723G>A,EXIT
MT-CYB,m.15761G>A,MM
MT-CYB,m.15762G>A,MM
MT-CYB,m.15773G>A,LHON
MT-CYB,m.15784T>C,POAG - potential for association
MT-CYB,m.15800C>T,EXIT / Myopathy
MT-CYB,m.15804T>C,Fibromyalgia
MT-CYB,m.15812G>A,LHON
MT-ND1,m.3308T>C,MELAS / DEAF enhancer / hypertension / LVNC / putative LHON
MT-ND1,m.3308T>G,Sudden Infant Death
MT-ND1,m.3310C>T,Diabetes / HCM
MT-ND1,m.3316G>A,Diabetes / LHON / PEO / vascular dementia
MT-ND1,m.3335T>C,LHON
MT-ND1,m.3336T>C,Carotid atherosclerosis risk
MT-ND1,m.3337G>A,Cardiomyopathy
MT-ND1,m.3340C>T,Encephaloneuromyopathy
MT-ND1,m.3365T>C,EXIT
MT-ND1,m.3376G>A,LHON MELAS overlap
MT-ND1,m.3380G>A,MELAS
MT-ND1,m.3388C>A,Materally Inherited Nonsyndromic Deafness
MT-ND1,m.3391G>A,LHON
MT-ND1,m.3394T>C,LHON / Diabetes / CPTdeficiency / high altitude adaptation
MT-ND1,m.3395A>G,LHON / HCM with hearing loss
MT-ND1,m.3396T>C,NSHL / MIDD
MT-ND1,m.3397A>G,ADPD / possibly LVNC-cardiomyopathy associated / resistance to high altitude pulmonary edema
MT-ND1,m.3398T>C,DMDF+HCM / GDM / possibly LVNC cardiomyopathy-associated
MT-ND1,m.3399A>T,Gestational Diabetes (GDM)
MT-ND1,m.3407G>A,HCM / Muscle involvement
MT-ND1,m.3418A>G,AMegL
MT-ND1,m.3421G>A,MIDD
MT-ND1,m.3437G>A,"Mitochondrial myopathy, EXIT"
MT-ND1,m.3460G>A,LHON
MT-ND1,m.3461C>T,LHON
MT-ND1,m.3472T>C,LHON
MT-ND1,m.3481G>A,MELAS / Progressive Encephalomyopathy
MT-ND1,m.3488T>C,LHON
MT-ND1,m.3496G>T,LHON
MT-ND1,m.3497C>T,LHON
MT-ND1,m.3502T>C,MELAS / MM w reversible COX deficiency
MT-ND1,m.3548T>C,Possible LHON helper (one 14484 patient)
MT-ND1,m.3551C>T,LHON
MT-ND1,m.3552T>A,Resistance to high altitude pulmonary edema (HAPE) / matrilineal hypertension
MT-ND1,m.3571del,Mitochondrial myopathy with reversible cytochrome C oxidase deficiency
MT-ND1,m.3571C>T,Possible LHON helper mut / idiopathic epilepsy
MT-ND1,m.3632C>T,LHON
MT-ND1,m.3634A>G,LHON
MT-ND1,m.3635G>A,LHON
MT-ND1,m.3644T>C,BD-associated
MT-ND1,m.3667T>G,Peripheral neuropathy of T2 diabetes
MT-ND1,m.3685T>C,Leigh Syndrome
MT-ND1,m.3688G>A,Leigh Syndrome
MT-ND1,m.3697G>A,MELAS / Leigh Syndrome / LDYT / BSN
MT-ND1,m.3700G>A,LHON
MT-ND1,m.3713T>C,LHON
MT-ND1,m.3733G>A,LHON
MT-ND1,m.3733G>C,LHON
MT-ND1,m.3734A>G,LHON
MT-ND1,m.3736G>A,LHON
MT-ND1,m.3745G>A,LHON / high altitude variant
MT-ND1,m.3761C>A,Deafness w relapsing/remitting neurological symptoms
MT-ND1,m.3769C>G,LHON
MT-ND1,m.3781T>C,LHON
MT-ND1,m.3796A>G,Adult-Onset Dystonia
MT-ND1,m.3833T>A,PEG
MT-ND1,m.3861A>C,SNHL + neurodevelopmental delay
MT-ND1,m.3866T>C,LHON + limb claudication
MT-ND1,m.3890G>A,Progressive Encephalomyopathy / Leigh Syndrome / Optic Atrophy
MT-ND1,m.3902_3908inv,EXIT+myalgia / severe LA+cardiac / 3-MGA aciduria / nephropathy+deafness+diabetes
MT-ND1,m.3919T>C,LHON
MT-ND1,m.3945C>A,Leigh-like phenotype
MT-ND1,m.3946G>A,MELAS
MT-ND1,m.3949T>C,MELAS
MT-ND1,m.3955G>A,Leigh Syndrome
MT-ND1,m.3958G>A,LHON
MT-ND1,m.3959G>A,MELAS
MT-ND1,m.3995A>G,MELAS
MT-ND1,m.4081T>C,LHON
MT-ND1,m.4115T>C,Possible LHON helper (one 11778 patient)
MT-ND1,m.4123A>T,LHON
MT-ND1,m.4132G>A,NAION-associated
MT-ND1,m.4135T>C,LHON
MT-ND1,m.4136A>G,LHON
MT-ND1,m.4142G>A,"Developmental delay, seizure, hypotonia"
MT-ND1,m.4142G>T,Leigh Syndrome
MT-ND1,m.4160T>C,LHON / LHON plus
MT-ND1,m.4163T>C,LHON
MT-ND1,m.4171C>A,LHON / Leigh-like phenotype
MT-ND1,m.4175G>A,EXIT
MT-ND1,m.4216T>C,LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage
MT-ND2,m.4491G>A,High altitude pulmonary edema susceptibility
MT-ND2,m.4516G>A,Possible LHON modulator
MT-ND2,m.4580G>A,Protective factor for stroke risk (hg V)
MT-ND2,m.4611del,Leigh Syndrome
MT-ND2,m.4633C>G,LHON candidate
MT-ND2,m.4640C>A,LHON / Epilepsy
MT-ND2,m.4648T>C,PEG
MT-ND2,m.4659G>A,possible PD risk factor / LHON
MT-ND2,m.4681T>C,Leigh Syndrome
MT-ND2,m.4769=,SZ-associated
MT-ND2,m.4810G>A,EXIT with myalgia & ophthalmoplegia
MT-ND2,m.4831G>A,Isolated myopathy
MT-ND2,m.4833A>G,"Diabetes helper mutation  AD, PD"
MT-ND2,m.4852T>A,LHON
MT-ND2,m.4883C>T,Glaucoma
MT-ND2,m.4917A>G,LHON / Insulin Resistance / AMD / NRTI-PN
MT-ND2,m.4924G>T,Possible LHON helper (one 11778 patient)
MT-ND2,m.4935A>G,Lipomatosis+EXIT
MT-ND2,m.4944A>G,High altitude pulmonary edema susceptibility
MT-ND2,m.4959G>A,Possible LHON helper (one 11778 patient)
MT-ND2,m.4983C>T,Unspecified suspected mitochondrial disorder
MT-ND2,m.5001_5002insA,"Developmental delay, seizure, cardiomyopathy, lactic acidosis"
MT-ND2,m.5095T>C,Proximal muscle weakness and atrophy
MT-ND2,m.5133_5134del,Exercise intolerance (EXIT)
MT-ND2,m.5153A>G,Recurrent pregnancy loss
MT-ND2,m.5178C>A,Longevity / Extraversion / diabetes / AMS protection / blood iron metabolism / correlation with myocardial infarction / atherosclerosis
MT-ND2,m.5244G>A,LHON
MT-ND2,m.5367_5385del,Unspecified suspected mitochondrial disorder
MT-ND2,m.5452C>T,Progressive Encephalomyopathy
MT-ND2,m.5460G>A,AD / PD / LHON
MT-ND2,m.5460G>T,AD
MT-ND3,m.10086A>G,Hypertensive end-stage renal disease
MT-ND3,m.10134C>A,Leigh Disease
MT-ND3,m.10142C>T,Recurrent pregnancy loss
MT-ND3,m.10158T>C,Leigh Disease / MELAS
MT-ND3,m.10189T>C,Behavior alteration with dilated cardiomyopathy
MT-ND3,m.10191T>C,Leigh Disease / ESOC
MT-ND3,m.10197G>A,Leigh Disease / Dystonia / Stroke / LDYT
MT-ND3,m.10197G>C,Leigh Disease
MT-ND3,m.10237T>C,LHON
MT-ND3,m.10254G>A,Leigh Disease
MT-ND3,m.10350C>A,LHON
MT-ND3,m.10372A>G,Sensorimotor axonal polyneuropathy
MT-ND3,m.10398=,Invasive Breast Cancer risk factor  AD  PD  BD lithium response  Type 2 DM
MT-ND3,m.10398A>G,PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy
MT-ND4,m.11042T>C,Biliary atresia
MT-ND4,m.11048del,Biliary atresia
MT-ND4,m.11084A>G,"AD, PD  MELAS"
MT-ND4,m.11150G>A,Found in a Multiple Sclerosis patient
MT-ND4,m.11232T>C,CPEO
MT-ND4,m.11240C>T,Leigh Syndrome
MT-ND4,m.11251A>G,Reduced risk of PD
MT-ND4,m.11253T>C,LHON  PD
MT-ND4,m.11365T>C,found in HCM patient
MT-ND4,m.11375A>C,found in sCJD patient
MT-ND4,m.11406T>A,MELAS
MT-ND4,m.11467A>G,Altered brain pH / sCJD patients
MT-ND4,m.11470A>C,MELAS
MT-ND4,m.11519A>C,ND4 mutation set found in a Multiple Sclerosis patient
MT-ND4,m.11523A>C,ND4 mutation set found in a Multiple Sclerosis patient
MT-ND4,m.11527C>T,ND4 mutation set found in a Multiple Sclerosis patient
MT-ND4,m.11621_11622del,"CPEO, exercise intolerance"
MT-ND4,m.11696G>A,LHON / LDYT / DEAF / hypertension helper mut.
MT-ND4,m.11777C>A,Leigh Disease
MT-ND4,m.11778G>A,LHON / Progressive Dystonia
MT-ND4,m.11832G>A,EXIT / oncocytoma
MT-ND4,m.11874C>A,LHON
MT-ND4,m.11914G>A,Possible susceptibility to bullous pemphigoid
MT-ND4,m.11919C>T,Thyroid Cancer Cell Line
MT-ND4,m.11984T>C,Leigh Syndrome
MT-ND4,m.11994C>T,Oligoasthenoteratozoospermia (OAT)
MT-ND4,m.12015T>C,Atypical MELAS
MT-ND4,m.12026A>G,DM
MT-ND4,m.12027T>C,SZ-associated
MT-ND4,m.12033A>G,LHON synergistic combo 10680A + 12033G + 14258A
MT-ND4,m.12063C>T,Recurrent pregnancy loss
MT-ND4L,m.10543A>G,LHON
MT-ND4L,m.10591T>G,LHON
MT-ND4L,m.10609T>C,Type 2 diabetes patients with underlying 3243G / LHON patient with 10663C
MT-ND4L,m.10652T>C,BD / MDD-associated
MT-ND4L,m.10663T>C,LHON
MT-ND4L,m.10676C>G,Type 2 cataract patients with underlying 3243G
MT-ND4L,m.10680G>A,LHON / synergistic combo 10680A + 12033G + 14258A
MT-ND5,m.12338T>C,DEAF1555 increased penetrance / LHON / MIDD
MT-ND5,m.12350C>A,SNHL + neurodevelopmental delay
MT-ND5,m.12361A>G,Non-alcoholic fatty liver disease
MT-ND5,m.12372G>A,Altered brain pH / sCJD patients
MT-ND5,m.12397A>G,"PD, early onset"
MT-ND5,m.12414del,EXIT
MT-ND5,m.12425del,Mitochondrial myopathy & renal failure
MT-ND5,m.12477T>C,Possible HCM susceptibility
MT-ND5,m.12622G>A,Leigh Disease
MT-ND5,m.12631T>A,found in 2 sCJD patients
MT-ND5,m.12634A>G,Thyroid Cancer Cell Line
MT-ND5,m.12662A>G,Recurrent pregnancy loss
MT-ND5,m.12686T>A,Dilated Cardiomyopathy
MT-ND5,m.12705C>T,Possible protective factor for normal tension glaucoma
MT-ND5,m.12706T>C,Leigh Disease
MT-ND5,m.12770A>G,MELAS
MT-ND5,m.12778G>C,Dilated Cardiomyopathy
MT-ND5,m.12782T>G,LHON
MT-ND5,m.12811T>C,Possible LHON factor
MT-ND5,m.12814G>T,LHON
MT-ND5,m.12848C>T,LHON
MT-ND5,m.12858C>A,Unspecified suspected mitochondrial disorder
MT-ND5,m.12923G>A,LHON/MELAS/LS
MT-ND5,m.12955A>G,EXIT and developmental delay
MT-ND5,m.13042G>A,Optic neuropathy/ retinopathy/ LD
MT-ND5,m.13045A>C,MELAS / LHON / Leigh overlap syndrome
MT-ND5,m.13045A>G,MELAS
MT-ND5,m.13046T>C,LHON/MELAS overlap syndrome
MT-ND5,m.13051G>A,LHON
MT-ND5,m.13063G>A,Adult-onset Encephalopathy / Ataxia
MT-ND5,m.13084A>T,MELAS / Leigh Disease
MT-ND5,m.13091T>C,MELAS+Migraine
MT-ND5,m.13094T>C,"Ataxia+PEO / MELAS, LD, LHON, myoclonus, fatigue"
MT-ND5,m.13135G>A,Possible HCM susceptibility
MT-ND5,m.13138G>A,Possible LHON modulator
MT-ND5,m.13204G>A,Peripheral neuropathy of T2 diabetes
MT-ND5,m.13271T>C,Exercise intolerance (EXIT)
MT-ND5,m.13276A>G,MIDD+retinopathy
MT-ND5,m.13289G>A,MELAS
MT-ND5,m.13340T>C,LHON
MT-ND5,m.13345G>A,LHON
MT-ND5,m.13376T>C,MELAS w medial temporal lobe atrophy
MT-ND5,m.13379A>C,LHON
MT-ND5,m.13379A>G,LHON
MT-ND5,m.13511A>T,Leigh-like syndrome
MT-ND5,m.13513G>A,Leigh Disease / MELAS / LHON-MELAS Overlap Syndrome / negative association w Carotid Atherosclerosis
MT-ND5,m.13514A>G,Leigh Disease / MELAS / Ca2+ downregulation
MT-ND5,m.13528A>G,"LHON-like, LHON, MELAS"
MT-ND5,m.13565C>T,Found in MELAS patient
MT-ND5,m.13580C>G,Thyroid Cancer
MT-ND5,m.13590G>A,Possible protective factor for high altitude sickness
MT-ND5,m.13615A>G,LHON
MT-ND5,m.13637A>G,Possible LHON factor
MT-ND5,m.13702C>G,Possible LHON helper (one 14484 patient)
MT-ND5,m.13708G>A,LHON / Increased MS risk / higher freq in PD-ADS
MT-ND5,m.13712C>T,Possible LHON helper (one 11778 patient)
MT-ND5,m.13730G>A,LHON
MT-ND5,m.13759G>A,Possible LHON factor
MT-ND5,m.13831C>A,Thyroid Cancer Cell Line
MT-ND5,m.13849A>C,MELAS
MT-ND5,m.13966A>G,Greater risk with hg X of end-stage kidney disease
MT-ND5,m.13967C>T,Possible LHON factor
MT-ND5,m.14002A>G,High altitude pulmonary edema susceptibility
MT-ND5,m.14063T>C,Potentially functional variant cosegregating with LHON3635A
MT-ND5,m.14091A>T,"Developmental delay, seizure, hearing loss, diabetes"
MT-ND6,m.14163C>T,Possible deafness factor
MT-ND6,m.14179A>G,Recurrent pregnancy loss
MT-ND6,m.14258G>A,LHON synergistic combo 10680A + 12033G + 14258A  also combo 14258A + 14582G
MT-ND6,m.14263C>T,Recurrent pregnancy loss
MT-ND6,m.14279G>A,LHON
MT-ND6,m.14319T>C,"PD, early onset"
MT-ND6,m.14325T>C,LHON
MT-ND6,m.14340C>T,SNHL
MT-ND6,m.14342C>A,Possible association with sepsis
MT-ND6,m.14351T>C,SNHL + neurodevelopmental delay
MT-ND6,m.14430A>C,Leigh Syndrome
MT-ND6,m.14430A>G,Thyroid Cancer / Leigh Syndrome
MT-ND6,m.14439G>A,LS / Mitochondrial Respiratory Chain Disorder
MT-ND6,m.14441T>C,Leigh-like phenotype
MT-ND6,m.14453G>A,MELAS / Leigh Disease
MT-ND6,m.14459G>A,LDYT / Leigh Disease / dystonia / carotid atherosclerosis risk
MT-ND6,m.14465G>A,LHON / various supected mitochondrial disease
MT-ND6,m.14482C>A,LHON
MT-ND6,m.14482C>G,LHON
MT-ND6,m.14484T>C,LHON
MT-ND6,m.14487T>C,Dystonia / Leigh Disease / ataxia / ptosis / epilepsy
MT-ND6,m.14495A>G,LHON
MT-ND6,m.14498T>C,LHON
MT-ND6,m.14502T>C,LHON
MT-ND6,m.14512_14513del,EXIT w mild myopathy & hyperCKaemia
MT-ND6,m.14535_14536insC,DMDF
MT-ND6,m.14538A>G,LHON
MT-ND6,m.14568C>T,LHON
MT-ND6,m.14577T>C,MIDM
MT-ND6,m.14582A>G,LHON synergistic combo 14258A + 14582G
MT-ND6,m.14596A>T,LHON with hereditary spastic dystonia
MT-ND6,m.14597A>G,LHON / LS
MT-ND6,m.14598T>C,PD / LS
MT-ND6,m.14600G>A,Leigh Disease w/optic atrophy / ASD mouse model
MT-ND6,m.14668C>T,Depressive Disorder associated
